Profile | GDS4284 / 225029_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4193.07 | 92 |
GSM687648 | Patient 402 control | 4915.18 | 93 |
GSM687653 | Patient 403 control | 5983.19 | 94 |
GSM687658 | Patient 404 control | 4623.18 | 93 |
GSM687663 | Patient 411 control | 5293.97 | 94 |
GSM687668 | Patient 422 control | 4721.39 | 93 |
GSM687673 | Patient 424 control | 4972.12 | 93 |
GSM687678 | Patient 425 control | 4129.92 | 92 |
GSM687683 | Patient 427 control | 4227.8 | 92 |
GSM687688 | Patient 428 control | 5169.33 | 94 |
GSM687695 | Patient 441 control | 2290.25 | 87 |
GSM687699 | Patient 443 control | 4918.27 | 93 |
GSM687704 | Patient 444 control | 2813.76 | 88 |
GSM687707 | Patient 448 control | 3979.65 | 92 |
GSM687712 | Patient 449 control | 4013.22 | 92 |
GSM687719 | Patient 450 control | 3164.82 | 90 |
GSM687724 | Patient 451 control | 2556.62 | 87 |
GSM687728 | Patient 452 control | 3336.35 | 90 |
GSM687646 | Patient 401 treated 24h | 5061.7 | 93 |
GSM687649 | Patient 402 treated 24h | 4469 | 92 |
GSM687665 | Patient 411 treated 24h | 4135.07 | 92 |
GSM687651 | Patient 402 treated 4 weeks | 4157.63 | 92 |
GSM687667 | Patient 411 treated 4 weeks | 4952.49 | 93 |
GSM687670 | Patient 422 treated 24h | 4425.47 | 92 |
GSM687671 | Patient 422 treated 4 weeks | 4760.76 | 93 |
GSM687654 | Patient 403 treated 24h | 5266.79 | 94 |
GSM687675 | Patient 424 treated 24h | 4904.33 | 93 |
GSM687685 | Patient 427 treated 24h | 4525.25 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 4886.96 | 93 |
GSM687677 | Patient 424 treated 4 weeks | 5227.22 | 94 |
GSM687687 | Patient 427 treated 4 weeks | 5141.08 | 93 |
GSM687692 | Patient 428 treated 4h | 4454.18 | 92 |
GSM687716 | Patient 449 treated 4h | 4289.21 | 92 |
GSM687722 | Patient 450 treated 4h | 2878.78 | 88 |
GSM687680 | Patient 425 treated 24h | 3934.44 | 91 |
GSM687690 | Patient 428 treated 24h | 4126.27 | 92 |
GSM687700 | Patient 443 treated 24h | 2925.75 | 89 |
GSM687705 | Patient 444 treated 24h | 3142.6 | 89 |
GSM687714 | Patient 449 treated 24h | 4312.52 | 92 |
GSM687721 | Patient 450 treated 24h | 2618.4 | 88 |
GSM687682 | Patient 425 treated 4 weeks | 4400.97 | 92 |
GSM687694 | Patient 428 treated 4 weeks | 4377.53 | 92 |
GSM687702 | Patient 443 treated 4 weeks | 4977.71 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 4580.99 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 3831.74 | 91 |
GSM687661 | Patient 404 treated 4h | 4860.84 | 93 |
GSM687710 | Patient 448 treated 4h | 3888.15 | 91 |
GSM687726 | Patient 451 treated 4h | 3139.67 | 89 |
GSM687730 | Patient 452 treated 4h | 5787.25 | 95 |
GSM687660 | Patient 404 treated 24h | 1992.4 | 85 |
GSM687697 | Patient 441 treated 24h | 2097.06 | 85 |
GSM687709 | Patient 448 treated 24h | 3545.68 | 90 |
GSM687725 | Patient 451 treated 24h | 2462.33 | 87 |
GSM687729 | Patient 452 treated 24h | 1734.61 | 84 |
GSM687727 | Patient 451 treated 4 weeks | 2784.57 | 88 |
GSM687731 | Patient 452 treated 4 weeks | 3452.05 | 90 |